- Home
- CLDT vs ATXS Comparison
CLDT vs ATXS Comparison
Compare CLDT & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDT
- ATXS
- Stock Information
- Founded
- CLDT 2009
- ATXS 2008
- Country
- CLDT United States
- ATXS United States
- Employees
- CLDT N/A
- ATXS N/A
- Industry
- CLDT Real Estate Investment Trusts
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- CLDT Real Estate
- ATXS Health Care
- Exchange
- CLDT Nasdaq
- ATXS Nasdaq
- Market Cap
- CLDT 351.7M
- ATXS 401.2M
- IPO Year
- CLDT 2010
- ATXS 2015
- Fundamental
- Price
- CLDT $7.02
- ATXS $5.22
- Analyst Decision
- CLDT Strong Buy
- ATXS Strong Buy
- Analyst Count
- CLDT 2
- ATXS 7
- Target Price
- CLDT $10.75
- ATXS $32.43
- AVG Volume (30 Days)
- CLDT 221.9K
- ATXS 607.7K
- Earning Date
- CLDT 08-01-2025
- ATXS 05-13-2025
- Dividend Yield
- CLDT 5.10%
- ATXS N/A
- EPS Growth
- CLDT N/A
- ATXS N/A
- EPS
- CLDT 0.06
- ATXS N/A
- Revenue
- CLDT $316,297,000.00
- ATXS N/A
- Revenue This Year
- CLDT N/A
- ATXS N/A
- Revenue Next Year
- CLDT $1.12
- ATXS N/A
- P/E Ratio
- CLDT $121.91
- ATXS N/A
- Revenue Growth
- CLDT 1.79
- ATXS N/A
- 52 Week Low
- CLDT $5.83
- ATXS $3.56
- 52 Week High
- CLDT $10.00
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- CLDT 46.68
- ATXS 61.30
- Support Level
- CLDT $7.05
- ATXS $3.83
- Resistance Level
- CLDT $7.25
- ATXS $4.98
- Average True Range (ATR)
- CLDT 0.14
- ATXS 0.39
- MACD
- CLDT -0.00
- ATXS 0.16
- Stochastic Oscillator
- CLDT 47.96
- ATXS 87.06
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.